These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11964844)

  • 1. Cytokines and chemokines in the immune response to hepatitis C infection.
    Heydtmann M; Shields P; McCaughan G; Adams D
    Curr Opin Infect Dis; 2001 Jun; 14(3):279-87. PubMed ID: 11964844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin.
    Jimenez-Sousa MA; Almansa R; de la Fuente C; Caro-Paton A; Ruiz L; Sanchez-Antolín G; Gonzalez JM; Aller R; Alcaide N; Largo P; Resino S; de Lejarazu RO; Bermejo-Martin JF
    Eur Cytokine Netw; 2010 Jun; 21(2):84-91. PubMed ID: 20483710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
    Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
    Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokines in hepatitis C virus-mediated liver disease.
    Brass A; Brenndörfer ED
    Int J Mol Sci; 2014 Mar; 15(3):4747-79. PubMed ID: 24646914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.
    Diepolder HM; Zachoval R; Hoffmann RM; Jung MC; Gerlach T; Pape GR
    J Mol Med (Berl); 1996 Oct; 74(10):583-8. PubMed ID: 8912179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adaptive cell immune response against the hepatitis C virus infection].
    Rallón NI; Soriano V; Benito JM
    Med Clin (Barc); 2007 Oct; 129(12):469-76. PubMed ID: 17953913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and HCV-related disorders.
    Fallahi P; Ferri C; Ferrari SM; Corrado A; Sansonno D; Antonelli A
    Clin Dev Immunol; 2012; 2012():468107. PubMed ID: 22611419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection.
    Irshad M; Gupta P; Irshad K
    Viral Immunol; 2019 Apr; 32(3):112-120. PubMed ID: 30817236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines.
    Jacobson Brown PM; Neuman MG
    Clin Biochem; 2001 May; 34(3):167-71. PubMed ID: 11408013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
    Ahlenstiel G; Woitas RP; Rockstroh J; Spengler U
    J Antimicrob Chemother; 2004 Jun; 53(6):895-8. PubMed ID: 15128728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in viral hepatitis.
    Koziel MJ
    Semin Liver Dis; 1999; 19(2):157-69. PubMed ID: 10422198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and HCV-related autoimmune disorders.
    Antonelli A; Ferrari SM; Ruffilli I; Fallahi P
    Immunol Res; 2014 Dec; 60(2-3):311-9. PubMed ID: 25381483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunopathogenesis of hepatitis C virus infection.
    Nelson DR
    Clin Liver Dis; 2001 Nov; 5(4):931-53. PubMed ID: 11685802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
    Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell recognition of hepatitis B and C viral antigens.
    Jung MC; Diepolder HM; Pape GR
    Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma].
    Thimme R; Spangenberg HC; Von Weizsäcker F; Blum HE
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2277-9. PubMed ID: 12397543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.